• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

日本终末期肾病接受肾脏替代治疗患者的流行趋势:1983 年至 2016 年日本透析治疗登记协会数据。

Secular trends in end-stage kidney disease requiring renal replacement therapy in Japan: Japanese Society of Dialysis Therapy Registry data from 1983 to 2016.

机构信息

Division of Comprehensive Geriatrics in Community, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan.

Department of Nephrology and Hypertension, Fukushima Medical University, Fukushima, Japan.

出版信息

Nephrology (Carlton). 2020 Feb;25(2):172-178. doi: 10.1111/nep.13595. Epub 2019 May 1.

DOI:10.1111/nep.13595
PMID:30980581
Abstract

AIM

We aimed to describe secular trends in the incidence of end-stage kidney disease (ESKD) requiring renal replacement therapy (RRT) in Japan, and to assess the effect of population aging on the incidence of ESKD.

METHODS

The national incidence of ESKD requiring RRT was calculated using published data and Japan's population statistics. Age-standardized incidence was calculated by direct standardization using the World Standard Population. The average annual percentage of change (APC) in rates and corresponding 95% confidence interval (CI) were computed for trends by joinpoint regression analysis. To assess the effect of population aging on the incidence of ESKD requiring RRT, we used the method proposed by Bashir and Estève, which splits the crude incidence into three components: population structure, population size, and age-independent risk.

RESULTS

Age-standardized incidence trends (1983-1996) increased significantly in both men (APC 6.33, 95% CI: 5.39-7.29) and women (APC 5.25, 95% CI: 4.26-6.24). With a significant inflection point in 1996, the trend was stable for men (APC -0.16, 95% CI: -0.48 to 0.17) but significantly decreased for women (APC -1.98, 95% CI: -2.38 to -1.59) from 1996 to 2016. The main reason for the increase in those with ESKD requiring RRT has changed; before 1996, the change in age-independent risk was the main contributor, but after 1996, the change in age structure with a higher proportion of older individuals was the main contributor.

CONCLUSION

The increase in number of ESKD patients requiring RRT dramatically changed in Japan during the 1983 to 2016 period.

摘要

目的

本研究旨在描述日本终末期肾病(ESKD)患者接受肾脏替代治疗(RRT)的发病率的长期变化趋势,并评估人口老龄化对 ESKD 发病率的影响。

方法

利用已发表的数据和日本人口统计资料计算接受 RRT 的 ESKD 的全国发病率。采用世界标准人口直接标准化法计算年龄标准化发病率。通过 Joinpoint 回归分析计算发病率变化的平均年百分比(APC)及其 95%置信区间(CI)。为了评估人口老龄化对 RRT 治疗的 ESKD 发病率的影响,我们采用了 Bashir 和 Estève 提出的方法,该方法将粗发病率分为三个组成部分:人口结构、人口规模和与年龄无关的风险。

结果

1983 年至 1996 年,男性(APC6.33,95%CI:5.39-7.29)和女性(APC5.25,95%CI:4.26-6.24)的年龄标准化发病率呈显著上升趋势。1996 年出现显著拐点后,男性的趋势保持稳定(APC-0.16,95%CI:-0.48 至 0.17),而女性的趋势则明显下降(APC-1.98,95%CI:-2.38 至-1.59),从 1996 年到 2016 年。需要 RRT 的 ESKD 患者数量增加的主要原因已经发生了变化;1996 年之前,与年龄无关的风险变化是主要原因,而 1996 年之后,年龄结构的变化(即老年人口比例更高)是主要原因。

结论

1983 年至 2016 年期间,日本需要接受 RRT 的 ESKD 患者数量急剧增加。

相似文献

1
Secular trends in end-stage kidney disease requiring renal replacement therapy in Japan: Japanese Society of Dialysis Therapy Registry data from 1983 to 2016.日本终末期肾病接受肾脏替代治疗患者的流行趋势:1983 年至 2016 年日本透析治疗登记协会数据。
Nephrology (Carlton). 2020 Feb;25(2):172-178. doi: 10.1111/nep.13595. Epub 2019 May 1.
2
Trends in the incidence of renal replacement therapy by type of primary kidney disease in Japan, 2006-2020.2006 - 2020年日本按原发性肾脏疾病类型划分的肾脏替代治疗发生率趋势
Nephrology (Carlton). 2023 Feb;28(2):119-129. doi: 10.1111/nep.14134. Epub 2022 Dec 8.
3
Trends in the Incidence of Renal Replacement Therapy Due to Rapidly Progressive Glomerulonephritis in Japan, 2006-2021.2006-2021 年日本快速进展性肾小球肾炎导致的肾脏替代治疗发病率趋势。
Intern Med. 2024 Oct 15;63(20):2751-2755. doi: 10.2169/internalmedicine.3343-23. Epub 2024 Mar 4.
4
Hip Fracture Trends in Japanese Dialysis Patients, 2008-2013.2008-2013 年日本透析患者的髋部骨折趋势。
Am J Kidney Dis. 2018 Feb;71(2):173-181. doi: 10.1053/j.ajkd.2017.07.017. Epub 2017 Nov 20.
5
Birth cohort effects in incident renal replacement therapy in Japan, 1982-2021.日本 1982-2021 年新增肾脏替代治疗的出生队列效应。
Clin Exp Nephrol. 2023 Aug;27(8):707-714. doi: 10.1007/s10157-023-02345-x. Epub 2023 Apr 4.
6
Prevalence and incidence of chronic kidney disease stage G5 in Japan.日本慢性肾脏病 G5 期的患病率和发病率。
Clin Exp Nephrol. 2015 Feb;19(1):54-64. doi: 10.1007/s10157-014-0978-x. Epub 2014 May 13.
7
Lifetime and age-conditional risk estimates of end-stage kidney disease requiring maintenance dialysis in Japan.日本维持性透析终末期肾病的终身和年龄条件风险估计。
Clin Exp Nephrol. 2020 Jun;24(6):518-525. doi: 10.1007/s10157-020-01860-5. Epub 2020 Feb 10.
8
Anticipated increase in the number of patients who require dialysis treatment among the aging population of Japan.预计日本老龄人口中需要透析治疗的患者数量将会增加。
Ther Apher Dial. 2015 Jun;19(3):201-6. doi: 10.1111/1744-9987.12266. Epub 2014 Dec 29.
9
Changes in excess mortality among adults with diabetes-related end-stage kidney disease: a comparison between the USA and Australia.糖尿病相关终末期肾病成人患者超额死亡率的变化:美国与澳大利亚的比较。
Nephrol Dial Transplant. 2022 Sep 22;37(10):2004-2013. doi: 10.1093/ndt/gfab315.
10
Characteristics and Outcomes of Patients With Systemic Sclerosis (Scleroderma) Requiring Renal Replacement Therapy in Europe: Results From the ERA-EDTA Registry.欧洲接受肾脏替代治疗的系统性硬化症(硬皮病)患者的特征和结局:来自 ERA-EDTA 登记处的结果。
Am J Kidney Dis. 2019 Feb;73(2):184-193. doi: 10.1053/j.ajkd.2018.05.016. Epub 2018 Aug 16.

引用本文的文献

1
Impact of dialysis on intravesical recurrence and survival outcomes in upper tract urothelial cancer patients undergoing radical nephroureterectomy.透析对接受根治性肾输尿管切除术的上尿路尿路上皮癌患者膀胱内复发及生存结局的影响。
Ren Fail. 2025 Dec;47(1):2458762. doi: 10.1080/0886022X.2025.2458762. Epub 2025 Feb 7.
2
Trends in the Incidence of Renal Replacement Therapy Due to Rapidly Progressive Glomerulonephritis in Japan, 2006-2021.2006-2021 年日本快速进展性肾小球肾炎导致的肾脏替代治疗发病率趋势。
Intern Med. 2024 Oct 15;63(20):2751-2755. doi: 10.2169/internalmedicine.3343-23. Epub 2024 Mar 4.
3
Establishment of a novel mouse model of renal artery coiling-based chronic hypoperfusion-related kidney injury.
建立一种基于肾动脉盘绕的慢性低灌注相关肾损伤的新型小鼠模型。
Biochem Biophys Rep. 2023 Dec 15;37:101607. doi: 10.1016/j.bbrep.2023.101607. eCollection 2024 Mar.
4
Birth cohort effects in incident renal replacement therapy in Japan, 1982-2021.日本 1982-2021 年新增肾脏替代治疗的出生队列效应。
Clin Exp Nephrol. 2023 Aug;27(8):707-714. doi: 10.1007/s10157-023-02345-x. Epub 2023 Apr 4.
5
Prefecture-specific prevalence of overweight/obesity is associated with regional variation in the incidence of treated ESKD in Japan.特定地区的超重/肥胖患病率与日本经治疗的终末期肾病发病率的地区差异有关。
Clin Exp Nephrol. 2023 Feb;27(2):132-140. doi: 10.1007/s10157-022-02284-z. Epub 2022 Oct 8.
6
Nephron overload as a therapeutic target to maximize kidney lifespan.以超负荷肾单位作为治疗靶点以延长肾脏寿命。
Nat Rev Nephrol. 2022 Mar;18(3):171-183. doi: 10.1038/s41581-021-00510-7. Epub 2021 Dec 8.